Ronnie Maitra, PhD, conducts preclinical drug discovery research related to metabolic syndrome and liver disease. His work in pharmacology has included studying the mechanisms of chemotherapy-induced differential regulation of ABC transporters CFTR and P-glycoprotein as well as preclinical drug discovery research related to cystic fibrosis, cannabinoid receptors, and alcohol-induced liver disease.
Previous to his work at RTI, Dr. Maitra was employed at Paradigm Genetics as the group leader of experimental biology, where his research focused on the discovery of predictive disease-related biomarkers using a systems biology approach.
